Biomedical applications of cell- and tissue-specific metabolic network models

Journal of Biomedical Informatics

Volumn 68, Issue , 2017, Pages 35-49

  Fouladiha, Hamideh ^a   Marashi, Sayed Amir ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Context specific metabolic models; Host microbe interaction; Metabolic network reconstruction; Systems biology

Indexed keywords

BACTERIA; BIOMARKERS; MEDICAL APPLICATIONS; MICROORGANISMS; TISSUE;

BIOMEDICAL APPLICATIONS; COMPUTATIONAL SIMULATION; GENOME-SCALE METABOLIC NETWORK; HOST-MICROBE INTERACTION; METABOLIC MODELS; METABOLIC NETWORK MODELS; METABOLIC NETWORK RECONSTRUCTION; SYSTEMS BIOLOGY;

METABOLISM;

BIOLOGICAL MARKER;

ADIPOCYTE; ADIPOSE TISSUE; BLOOD VESSEL; BRAIN; CANCER CELL; CELL METABOLISM; ERYTHROCYTE; HEART; HUMAN; HUMAN GENOME; IMMUNOCOMPETENT CELL; INTESTINE CELL; KIDNEY; LIVER; MEDICAL RESEARCH; MICROFLORA; MUSCLE; NONHUMAN; REVIEW; SPERM; STEM CELL; SYSTEMS BIOLOGY; THROMBOCYTE; TISSUE METABOLISM; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENOME; METABOLISM; RESEARCH;

COMPUTER SIMULATION; GENOME; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; RESEARCH; SYSTEMS BIOLOGY;

EID: 85014511954     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2017.02.014     Document Type: Review

References (181)

1. [1] Cairns, R.A., Harris, I.S., Mak, T.W., Regulation of cancer cell metabolism. Nat. Rev. Cancer 11 (2011), 85–95.
2. [2] Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
3. [3] Mo, M.L., Jamshidi, N., Palsson, B.Ø., A genome-scale, constraint-based approach to systems biology of human metabolism. Mol. BioSyst. 3 (2007), 598–603.
4. [4] Bordbar, A., Monk, J.M., King, Z.A., Palsson, B.Ø., Constraint-based models predict metabolic and associated cellular functions. Nat. Rev. Genet. 15 (2014), 107–120.
5. [5] Oberhardt, M.A., Palsson, B.Ø., Papin, J.A., Applications of genome-scale metabolic reconstructions. Mol. Syst. Biol., 5, 2009, 320.
6. [6] Feist, A.M., Palsson, B.Ø., The biomass objective function. Curr. Opin. Microbiol. 13 (2010), 344–349.
7. [7] Marashi, S.-A., Constraint-based Analysis of Substructures of Metabolic Networks. [Doctoral Thesis, Ph.D. Thesis], 2011, Freie Universität Berlin, Berlin, Germany.
8. [8] Higgins, J., A chemical mechanism for oscillation of glycolytic intermediates in yeast cells. Proc. Natl. Acad. Sci. U.S.A. 51 (1964), 989–994.
9. [9] Nolan, R.P., Lee, K., Dynamic model of CHO cell metabolism. Metab. Eng. 13 (2011), 108–124.
10. [10] Orth, J.D., Thiele, I., Palsson, B.Ø., What is flux balance analysis?. Nat. Biotechnol. 28 (2010), 245–248.
11. [11] Fell, D.A., Small, J.R., Fat synthesis in adipose tissue. An examination of stoichiometric constraints. Biochem. J. 238 (1986), 781–786.
12. [12] Varma, A., Palsson, B.Ø., Metabolic capabilities of Escherichia coli II. Optimal growth patterns. J. Theor. Biol. 165 (1993), 503–522.
13. [13] Nagrath, D., Avila-Elchiver, M., Berthiaume, F., Tilles, A.W., Messac, A., Yarmush, M.L., Integrated energy and flux balance based multiobjective framework for large-scale metabolic networks. Ann. Biomed. Eng. 35 (2007), 863–885.
14. [14] Wagner, A., Zarecki, R., Reshef, L., Gochev, C., Sorek, R., Gophna, U., et al. Computational evaluation of cellular metabolic costs successfully predicts genes whose expression is deleterious. Proc. Natl. Acad. Sci. 110 (2013), 19166–19171.
15. [15] Vo, T.D., Greenberg, H.J., Palsson, B.Ø., Reconstruction and functional characterization of the human mitochondrial metabolic network based on proteomic and biochemical data. J. Biol. Chem. 279 (2004), 39532–39540.
16. [16] Edwards, J.S., Palsson, B.Ø., Systems properties of the Haemophilus influenzae Rd metabolic genotype. J. Biol. Chem. 274 (1999), 17410–17416.
17. [17] Edwards, J.S., Ibarra, R.U., Palsson, B.Ø., In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat. Biotechnol. 19 (2001), 125–130.
18. [18] Feist, A.M., Herrgard, M.J., Thiele, I., Reed, J.L., Palsson, B.Ø., Reconstruction of biochemical networks in microorganisms. Nat. Rev. Microbiol. 7 (2009), 129–143.
19. [19] Kim, T.Y., Sohn, S.B., Kim, Y.B., Kim, W.J., Lee, S.Y., Recent advances in reconstruction and applications of genome-scale metabolic models. Curr. Opin. Biotechnol. 23 (2012), 617–623.
20. [20] Thiele, I., Vo, T.D., Price, N.D., Palsson, B.Ø., Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J. Bacteriol. 187 (2005), 5818–5830.
21. [21] Durot, M., Le Fevre, F., de Berardinis, V., Kreimeyer, A., Vallenet, D., Combe, C., et al. Iterative reconstruction of a global metabolic model of Acinetobacter baylyi ADP1 using high-throughput growth phenotype and gene essentiality data. BMC Syst. Biol., 2, 2008, 85.
22. [22] Puchałka, J., Oberhardt, M.A., Godinho, M., Bielecka, A., Regenhardt, D., Timmis, K.N., et al. Genome-scale reconstruction and analysis of the Pseudomonas putida KT2440 metabolic network facilitates applications in biotechnology. PLoS Comput. Biol., 4, 2008, e1000210.
23. [23] Garcia-Albornoz, M.A., Nielsen, J., Application of genome-scale metabolic models in metabolic engineering. Ind. Biotechnol. 9 (2013), 203–214.
24. [24] Oberhardt, M.A., Yizhak, K., Ruppin, E., Metabolically re-modeling the drug pipeline. Curr. Opin. Pharmacol. 13 (2013), 778–785.
25. [25] Pál, C., Papp, B., Lercher, M.J., Csermely, P., Oliver, S.G., Hurst, L.D., Chance and necessity in the evolution of minimal metabolic networks. Nature 440 (2006), 667–670.
26. [26] Yizhak, K., Tuller, T., Papp, B., Ruppin, E., Metabolic modeling of endosymbiont genome reduction on a temporal scale. Mol. Syst. Biol., 7, 2011, 479.
27. [27] Marashi, S.-A., Kouhestani, H., Mahdavi, M., Studying the relationship between robustness against mutations in metabolic networks and lifestyle of organisms. Sci. World J., 2013, 2013, 615697.
28. [28] Romero, P., Wagg, J., Green, M., Kaiser, D., Krummenacker, M., Karp, P., Computational prediction of human metabolic pathways from the complete human genome. Genome Biol., 6, 2004, R2.
29. [29] Ma, H., Sorokin, A., Mazein, A., Selkov, A., Selkov, E., Demin, O., et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol. Syst. Biol., 3, 2007, 135.
30. [30] Duarte, N.C., Becker, S.A., Jamshidi, N., Thiele, I., Mo, M.L., Vo, T.D., et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 1777–1782.
31. [31] Hao, T., Ma, H.-W., Zhao, X.-M., Goryanin, I., Compartmentalization of the Edinburgh Human Metabolic Network. BMC Bioinform., 11, 2010, 393.
32. [32] Shlomi, T., Cabili, M.N., Ruppin, E., Predicting metabolic biomarkers of human inborn errors of metabolism. Mol. Syst. Biol., 5, 2009, 263.
33. [33] McKusick, V.A., Mendelian inheritance in man and its online version. OMIM: Am. J. Hum. Genet. 80 (2007), 588–604.
34. [34] Töpel, T., Hofestädt, R., Scheible, D., Trefz, F., RAMEDIS: the rare metabolic diseases database. Appl. Bioinform. 5 (2006), 115–118.
35. [35] Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., Nielsen, J., Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol., 8, 2012, e1002518.
36. [36] Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., et al. Towards a knowledge-based human protein atlas. Nat. Biotechnol. 28 (2010), 1248–1250.
37. [37] Wishart, D.S., Tzur, D., Knox, C., Eisner, R., Guo, A.C., Young, N., et al. HMDB: the human metabolome database. Nucleic Acids Res. 35 (2007), 521–526.
38. [38] Thiele, I., Swainston, N., Fleming, R.M.T., Hoppe, A., Sahoo, S., Aurich, M.K., et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31 (2013), 419–425.
39. [39] Salazar, D.A., Rodríguez-López, A., Herreño, A., Barbosa, H., Herrera, J., Ardila, A., et al. Systems biology study of mucopolysaccharidosis using a human metabolic reconstruction network. Mol. Genet. Metab. 117 (2016), 129–139.
40. [40] Swainston, N., Smallbone, K., Hefzi, H., Dobson, P.D., Brewer, J., Hanscho, M., et al. Recon 2.2: from reconstruction to model of human metabolism. Metabolomics 12 (2016), 109–115.
41. [41] Fan, J., Ye, J., Kamphorst, J.J., Shlomi, T., Thompson, C.B., Rabinowitz, J.D., Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510 (2014), 298–302.
42. [42] Rohatgi, N., Nielsen, T.K., Bjørn, S.P., Axelsson, I., Paglia, G., Voldborg, B.G., et al. Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis. PLoS ONE, 9, 2014, e98760.
43. [43] Rolfsson, Ó., Paglia, G., Magnusdóttir, M., Palsson, B.Ø., Thiele, I., Inferring the metabolism of human orphan metabolites from their metabolic network context affirms human gluconokinase activity. Biochem. J. 449 (2013), 427–435.
44. [44] Rolfsson, Ó., Palsson, B.Ø., Thiele, I., The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions. BMC Syst. Biol., 5, 2011, 155.
45. [45] Hyduke, D.R., Lewis, N.E., Palsson, B.Ø., Analysis of omics data with genome-scale models of metabolism. Mol. BioSyst. 9 (2013), 167–174.
46. [46] Deo, R.C., Hunter, L., Lewis, G.D., Pare, G., Vasan, R.S., Chasman, D., et al. Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput. Biol., 6, 2010, e1000692.
47. [47] Zelezniak, A., Pers, T.H., Soares, S., Patti, M.E., Patil, K.R., Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput. Biol., 6, 2010, e1000729.
48. [48] Stempler, S., Yizhak, K., Ruppin, E., Integrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for Alzheimer's disease. PLoS ONE, 9, 2014, e105383.
49. [49] Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol., 9, 2013, 649.
50. [50] Jerby, L., Shlomi, T., Ruppin, E., Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol. Syst. Biol., 6, 2010, 401.
51. [51] Becker, S.A., Palsson, B.Ø., Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol., 4, 2008, e1000082.
52. [52] Wang, Y., Eddy, J., Price, N., Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol., 6, 2012, 153.
53. [53] Schultz, A., Qutub, A.A., Reconstruction of tissue-specific metabolic networks using CORDA. PLoS Comput. Biol., 12, 2016, e1004808.
54. [54] Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., Nielsen, J., Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol., 10, 2014, 721.
55. [55] Gille, C., Bölling, C., Hoppe, A., Bulik, S., Hoffmann, S., Hübner, K., et al. HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol., 6, 2010, 411.
56. [56] Pagliarini, R., di Bernardo, D., A genome-scale modeling approach to study inborn errors of liver metabolism: toward an in silico patient. J. Comput. Biol. 20 (2013), 383–397.
57. [57] Yang, H., Roth, C.M., Ierapetritou, M.G., A rational design approach for amino acid supplementation in hepatocyte culture. Biotechnol. Bioeng. 103 (2009), 1176–1191.
58. [58] Izamis, M.L., Sharma, N.S., Uygun, B., Bieganski, R., Saeidi, N., Nahmias, Y., et al. In situ metabolic flux analysis to quantify the liver metabolic response to experimental burn injury. Biotechnol. Bioeng. 108 (2011), 839–852.
59. [59] Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., Nielsen, J., Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun., 5, 2014, 3083.
60. [60] Zhao, Y., Huang, J., Reconstruction and analysis of human heart-specific metabolic network based on transcriptome and proteome data. Biochem. Biophys. Res. Commun. 415 (2011), 450–454.
61. [61] Karlstädt, A., Fliegner, D., Kararigas, G., Ruderisch, H.S., Regitz-Zagrosek, V., Holzhütter, H.G., CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism. BMC Syst. Biol., 6, 2012, 114.
62. [62] Chang, R.L., Xie, L., Xie, L., Bourne, P.E., Palsson, B.Ø., Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput. Biol., 6, 2010, e1000938.
63. [63] Zhang, A.-D., Dai, S.-X., Huang, J.-F., Reconstruction and analysis of human kidney-specific metabolic network based on omics data. BioMed. Res. Int., 2013, 2013, 187509.
64. [64] Sohrabi-Jahromi, S., Marashi, S.-A., Kalantari, S., A kidney-specific genome-scale metabolic network model for analyzing focal segmental glomerulosclerosis. Mamm. Genome 27 (2016), 158–167.
65. [65] Quek, L.-E., Dietmair, S., Hanscho, M., Martínez, V.S., Borth, N., Nielsen, L.K., Reducing recon 2 for steady-state flux analysis of HEK cell culture. J. Biotechnol. 184 (2014), 172–178.
66. [66] Bordbar, A., Jamshidi, N., Palsson, B.Ø., iAB-RBC-283: a proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states. BMC Syst. Biol., 5, 2011, 110.
67. + T cell metabolism, immunometabolism and application in drug design. Mol. BioSyst. 12 (2016), 431–443.
68. [68] Patella, F., Schug, Z.T., Persi, E., Neilson, L.J., Erami, Z., Avanzato, D., et al. Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. Mol. Cell. Proteom.: MCP 14 (2015), 621–634.
69. [69] Sahoo, S., Thiele, I., Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells. Hum. Mol. Genet. 22 (2013), 2705–2722.
70. [70] Fouladiha, H., Marashi, S.A., Shokrgozar, M.A., Reconstruction and validation of a constraint-based metabolic network model for bone marrow-derived mesenchymal stem cells. Cell Prolif. 48 (2015), 475–485.
71. [71] Thomas, A., Rahmanian, S., Bordbar, A., Palsson, B.Ø., Jamshidi, N., Network reconstruction of platelet metabolism identifies metabolic signature for aspirin resistance. Sci. Rep., 4, 2014, 3925.
72. [72] Väremo, L., Scheele, C., Broholm, C., Mardinoglu, A., Kampf, C., Asplund, A., et al. Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. Cell Rep. 11 (2015), 921–933.
73. [73] Nogiec, C., Burkart, A., Dreyfuss, J.M., Lerin, C., Kasif, S., Patti, M.-E., Metabolic modeling of muscle metabolism identifies key reactions linked to insulin resistance phenotypes. Mol. Metab. 4 (2015), 151–163.
74. [74] Asghari, A., Marashi, S.-A., Ansari-Pour, N., A sperm-specific proteome-scale metabolic network model identifies non-glycolytic genes for energy deficiency in asthenozoospermia. Syst. Biol. Reprod. Med., 2017, 10.1080/19396368.2016.1263367.
75. [75] Orman, M.A., Mattick, J., Androulakis, I.P., Berthiaume, F., Ierapetritou, M.G., Stoichiometry based steady-state hepatic flux analysis: computational and experimental aspects. Metabolites 2 (2012), 268–291.
76. [76] Yang, H., Roth, C.M., Ierapetritou, M.G., Analysis of amino acid supplementation effects on hepatocyte cultures using flux balance analysis. OMICS 15 (2011), 449–460.
77. [77] Lemieux, H., Hoppel, C.L., Mitochondria in the human heart. J. Bioenerg. Biomembr. 41 (2009), 99–106.
78. [78] Thiele, I., Price, N.D., Vo, T.D., Palsson, B.Ø., Candidate metabolic network states in human mitochondria: impact of diabetes, ischemia, and diet. J. Biol. Chem. 280 (2005), 11683–11695.
79. [79] Jamshidi, N., Palsson, B.Ø., Systems biology of SNPs. Mol. Syst. Biol., 2, 2006, 38.
80. [80] Edwards, L.M., Sigurdsson, M.I., Robbins, P.A., Weale, M.E., Cavalleri, G.L., Montgomery, H.E., et al. Genome-scale methods converge on key mitochondrial genes for the survival of human cardiomyocytes in hypoxia. Circ. Cardiovasc. Genet. 7 (2014), 407–415.
81. [81] Obrzut, S., Tiongson, J., Jamshidi, N., Phan, H., Hoh, C., Birgersdotter-Green, U., Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy. J. Cardiovasc. Trans. Res. 3 (2010), 643–651.
82. [82] Monteiro, R., Azevedo, I., Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm., 2010 289645.
83. [83] Mathis, D., Shoelson, S.E., Immunometabolism: an emerging frontier. Nat. Rev. Immunol. 11 (2011), 81–83.
84. [84] Wu, Z., Pan, D., Macrophage in intestinal immunity and inflammation: a brief review. Macrophage, 2, 2015, 869.
85. [85] Bordbar, A., Mo, M.L., Nakayasu, E.S., Schrimpe-Rutledge, A.C., Kim, Y.M., Metz, T.O., et al. Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation. Mol. Syst. Biol., 8, 2012, 558.
86. [86] Bordbar, A., Lewis, N.E., Schellenberger, J., Palsson, B.Ø., Jamshidi, N., Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol., 6, 2010, 422.
87. [87] Pollizzi, K.N., Powell, J.D., Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14 (2014), 435–446.
88. [88] Wiback, S.J., Palsson, B.O., Extreme pathway analysis of human red blood cell metabolism. Biophys. J. 83 (2002), 808–818.
89. [89] Barrett, C.L., Price, N.D., Palsson, B.O., Network-level analysis of metabolic regulation in the human red blood cell using random sampling and singular value decomposition. BMC Bioinform., 7, 2006, 132.
90. [90] Price, N.D., Schellenberger, J., Palsson, B.Ø., Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. Biophys. J. 87 (2004), 2172–2186.
91. [91] Cristancho, A.G., Lazar, M.A., Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 12 (2011), 722–734.
92. [92] Goddard, L.M., Iruela-Arispe, M.L., Cellular and molecular regulation of vascular permeability. Thromb. Haemost. 109 (2013), 407–415.
93. [93] Petersen, K.F., Dufour, S., Shulman, G.I., Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med., 2, 2005, 879.
94. [94] Lewis, N.E., Abdel-Haleem, A.M., The evolution of genome-scale models of cancer metabolism. Front. Physiol., 4, 2013, 237.
95. [95] Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., Shlomi, T., Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol., 7, 2011, 501.
96. [96] Hadi, M., Marashi, S.A., Reconstruction of a generic metabolic network model of cancer cells. Mol. BioSyst. 10 (2014), 3014–3021.
97. [97] Banta, S., Vemula, M., Yokoyama, T., Jayaraman, A., Berthiaume, F., Yarmush, M.L., Contribution of gene expression to metabolic fluxes in hypermetabolic livers induced through burn injury and cecal ligation and puncture in rats. Biotechnol. Bioeng. 97 (2007), 118–137.
98. [98] Di Filippo, M., Colombo, R., Damiani, C., Pescini, D., Gaglio, D., Vanoni, M., et al. Zooming-in on cancer metabolic rewiring with tissue specific constraint-based models. Comput. Biol. Chem. 62 (2016), 60–69.
99. [99] Yizhak, K., Le Dévédec, S.E., Rogkoti, V.M., Baenke, F., de Boer, V.C., Frezza, C., et al. A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol. Syst. Biol., 10, 2014, 744.
100. [100] Gatto, F., Miess, H., Schulze, A., Nielsen, J., Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism. Sci. Rep., 5, 2015, 10738.
101. [101] Frezza, C., Zheng, L., Folger, O., Rajagopalan, K.N., MacKenzie, E.D., Jerby, L., et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477 (2011), 225–228.
102. [102] Megchelenbrink, W., Katzir, R., Lu, X., Ruppin, E., Notebaart, R.A., Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival. Proc. Natl. Acad. Sci. 112 (2015), 12217–12222.
103. [103] Ghaffari, P., Mardinoglu, A., Asplund, A., Shoaie, S., Kampf, C., Uhlen, M., et al. Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling. Sci. Rep., 5, 2015, 8183.
104. [104] Nam, H., Campodonico, M., Bordbar, A., Hyduke, D.R., Kim, S., Zielinski, D.C., et al. A systems approach to predict oncometabolites via context-specific genome-scale metabolic networks. PLoS Comput. Biol., 10, 2014, e1003837.
105. [105] Motamedian, E., Ghavami, G., Sardari, S., Investigation on metabolism of cisplatin resistant ovarian cancer using a genome scale metabolic model and microarray data. Iran. J. Basic Med. Sci. 18 (2015), 267–276.
106. [106] Jerby, L., Wolf, L., Denkert, C., Stein, G.Y., Hilvo, M., Oresic, M., et al. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res. 72 (2012), 5712–5720.
107. [107] Omasa, T., Onitsuka, M., Kim, W.-D., Cell engineering and cultivation of Chinese hamster ovary (CHO) cells. Curr. Pharm. Biotechnol. 11 (2010), 233–240.
108. [108] Trill, J.J., Shatzman, A.R., Subinay, G., Production of monoclonal antibodies in COS and CHO cells. Curr. Opin. Biotechnol. 6 (1995), 553–560.
109. [109] Selvarasu, S., Ho, Y.S., Chong, W.P., Wong, N.S., Yusufi, F.N., Lee, Y.Y., et al. Combined in silico modeling and metabolomics analysis to characterize fed-batch CHO cell culture. Biotechnol. Bioeng. 109 (2012), 1415–1429.
110. [110] Thomas, P., Smart, T.G., HEK293 cell line: a vehicle for the expression of recombinant proteins. J. Pharmacol. Toxicol. Methods 51 (2005), 187–200.
111. [111] Burns, C.E., Zon, L.I., Portrait of a stem cell. Dev. Cell 3 (2002), 612–613.
112. [112] Mitsiadis, T.A., Barrandon, O., Rochat, A., Barrandon, Y., De Bari, C., Stem cell niches in mammals. Exp. Cell Res. 313 (2007), 3377–3385.
113. [113] Sepúlveda, D.E., Andrews, B.A., Papoutsakis, E.T., Asenjo, J.A., Metabolic flux analysis of embryonic stem cells using three distinct differentiation protocols and comparison to gene expression patterns. Biotechnol. Prog. 26 (2010), 1222–1229.
114. [114] Varma, A., Palsson, B.Ø., Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl. Environ. Microbiol. 60 (1994), 3724–3731.
115. [115] Pentjuss, A., Rubenis, O., Bauze, D., Aprupe, L., Lace, B., Flux variability analysis approach of autism related metabolism in stoichiometric model of mitochondria. Biosyst. Inform. Technol. 2 (2013), 37–42.
116. [116] Bordbar, A., Feist, A.M., Usaite-Black, R., Woodcock, J., Palsson, B.Ø., Famili, I., A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. Biol., 5, 2011, 180.
117. [117] Çakιr, T., Alsan, S., Saybaşili, H., Akιn, A., Ülgen, K.Ö., Reconstruction and flux analysis of coupling between metabolic pathways of astrocytes and neurons: application to cerebral hypoxia. Theor. Biol. Med. Modell., 4, 2007, 48.
118. [118] Segrè, D., Vitkup, D., Church, G.M., Analysis of optimality in natural and perturbed metabolic networks. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 15112–15117.
119. [119] Occhipinti, R., Puchowicz, M.A., LaManna, J.C., Somersalo, E., Calvetti, D., Statistical analysis of metabolic pathways of brain metabolism at steady state. Ann. Biomed. Eng. 35 (2007), 886–902.
120. [120] Sertbaş, M., Ülgen, K., Çakır, T., Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network. FEBS Open Bio. 4 (2014), 542–553.
121. [121] Lewis, N.E., Schramm, G., Bordbar, A., Schellenberger, J., Andersen, M.P., Cheng, J.K., et al. Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat. Biotechnol. 28 (2010), 1279–1285.
122. [122] Gibson, G.E., Zhang, H., Sheu, K.F., Bogdanovich, N., Lindsay, J.G., Lannfelt, L., et al. Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann. Neurol. 44 (1998), 676–681.
123. [123] Fukui, H., Diaz, F., Garcia, S., Moraes, C.T., Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 14163–14168.
124. [124] Liang, W.S., Dunckley, T., Beach, T.G., Grover, A., Mastroeni, D., Ramsey, K., et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol. Genomics 33 (2008), 240–256.
125. [125] Karlsson, F., Tremaroli, V., Nielsen, J., Bäckhed, F., Assessing the human gut microbiota in metabolic diseases. Diabetes 62 (2013), 3341–3349.
126. [126] Consortium HMP, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
127. [127] Shoaie, S., Karlsson, F., Mardinoglu, A., Nookaew, I., Bordel, S., Nielsen, J., Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci. Rep., 3, 2013, 2532.
128. [128] Abubucker, S., Segata, N., Goll, J., Schubert, A.M., Izard, J., Cantarel, B.L., et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol., 8, 2012, e1002358.
129. [129] Thiele, I., Heinken, A., Fleming, R.M., A systems biology approach to studying the role of microbes in human health. Curr. Opin. Biotechnol. 24 (2013), 4–12.
130. [130] Klitgord, N., Segrè, D., The importance of compartmentalization in metabolic flux models: yeast as an ecosystem of organelles. Genome Inform. 22 (2010), 41–55.
131. [131] Heinken, A., Sahoo, S., Fleming, R.M., Thiele, I., Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microb. 4 (2013), 28–40.
132. [132] Shoaie, S., Nielsen, J., Elucidating the interactions between the human gut microbiota and its host through metabolic modeling. Front. Genet., 5, 2014, 86.
133. [133] Fatumo, S., Plaimas, K., Adebiyi, E., König, R., Comparing metabolic network models based on genomic and automatically inferred enzyme information from Plasmodium and its human host to define drug targets in silico. Infect. Genet. Evol. 11 (2011), 201–208.
134. [134] Kim, H.U., Kim, S.Y., Jeong, H., Kim, T.Y., Kim, J.J., Choy, H.E., et al. Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol. Syst. Biol., 7, 2011, 460.
135. [135] Song, C., Chiasson, M.A., Nursimulu, N., Hung, S.S., Wasmuth, J., Grigg, M.E., et al. Metabolic reconstruction identifies strain-specific regulation of virulence in Toxoplasma gondii. Mol. Syst. Biol., 9, 2013, 708.
136. [136] Raghunathan, A., Reed, J., Shin, S., Palsson, B., Daefler, S., Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction. BMC Syst. Biol., 3, 2009, 38.
137. [137] Raghunathan, A., Shin, S., Daefler, S., Systems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensis. BMC Syst. Biol., 4, 2010, 118.
138. [138] Huthmacher, C., Hoppe, A., Bulik, S., Holzhutter, H.G., Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst. Biol., 4, 2010, 120.
139. [139] Bazzani, S., Hoppe, A., Holzhütter, H.G., Network-based assessment of the selectivity of metabolic drug targets in Plasmodium falciparum with respect to human liver metabolism. BMC Syst. Biol., 6, 2012, 118.
140. [140] Elsemman, I.E., Mardinoglu, A., Shoaie, S., Soliman, T.H., Nielsen, J., Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism. Mol. BioSyst. 12 (2016), 1496–1506.
141. [141] Shlomi, T., Eisenberg, Y., Sharan, R., Ruppin, E., A genome-scale computational study of the interplay between transcriptional regulation and metabolism. Mol. Syst. Biol., 3, 2007, 101.
142. [142] Yizhak, K., Benyamini, T., Liebermeister, W., Ruppin, E., Shlomi, T., Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics 26 (2010), 255–260.
143. [143] Großeholz, R., Koh, C.-C., Veith, N., Fiedler, T., Strauss, M., Olivier, B., et al. Integrating highly quantitative proteomics and genome-scale metabolic modeling to study pH adaptation in the human pathogen Enterococcus faecalis. NPJ Syst. Biol. Appl., 2, 2016, 16017.
144. [144] Feist, A.M., Palsson, B.O., What do cells actually want?. Genome Biol., 17, 2016, 110.
145. [145] Yizhak, K., Gabay, O., Cohen, H., Ruppin, E., Model-based identification of drug targets that revert disrupted metabolism and its application to ageing. Nat. Commun., 4, 2013, 2632.
146. [146] Nguyen, H.B., Rivers, E.P., Abrahamian, F.M., Moran, G.J., Abraham, E., Trzeciak, S., et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann. Emerg. Med. 48 (2006), 28–54.
147. [147] Cohen, J., Vincent, J.-L., Adhikari, N.K., Machado, F.R., Angus, D.C., Calandra, T., et al. Sepsis: a roadmap for future research. Lancet. Infect. Dis 15 (2015), 581–614.
148. [148] Lee, W.L., Slutsky, A.S., Sepsis and endothelial permeability. N. Engl. J. Med. 363 (2010), 689–691.
149. [149] Calandra, T., Gerain, J., Heumann, D., Baumgartner, J.-D., Glauser, M.P., Group S-DJIS. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am. J. Med. 91 (1991), 23–29.
150. [150] Sims, N.A., Vrahnas, C., Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts. Arch. Biochem. Biophys. 561 (2014), 22–28.
151. [151] Prideaux, M., Findlay, D.M., Atkins, G.J., Osteocytes: the master cells in bone remodelling. Curr. Opin. Pharmacol. 28 (2016), 24–30.
152. [152] Peel, N., Disorders of bone metabolism. Surgery (Oxford) 33 (2015), 15–20.
153. [153] Krauss, M., Schaller, S., Borchers, S., Findeisen, R., Lippert, J., Kuepfer, L., Integrating cellular metabolism into a multiscale whole-body model. PLoS Comput. Biol., 8, 2012, e1002750.
154. [154] Chang, R.L., Xie, L., Bourne, P.E., Palsson, B.Ø., Antibacterial mechanisms identified through structural systems pharmacology. BMC Syst. Biol., 7, 2013, 102.
155. [155] Hyduke, D.R., Palsson, B.Ø., Towards genome-scale signalling network reconstructions. Nat. Rev. Genet. 11 (2010), 297–307.
156. [156] Chandrasekaran, S., Price, N.D., Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 17845–17850.
157. [157] Covert, M.W., Knight, E.M., Reed, J.L., Herrgård, M.J., Palsson, B.O., Integrating high-throughput and computational data elucidates bacterial networks. Nature 429 (2004), 92–96.
158. [158] Lee, J.M., Gianchandani, E.P., Eddy, J.A., Papin, J.A., Dynamic analysis of integrated signaling, metabolic, and regulatory networks. PLoS Comput. Biol., 4, 2008, e1000086.
159. [159] Karr, J.R., Sanghvi, J.C., Macklin, D.N., Gutschow, M.V., Jacobs, J.M., Bolival, B. Jr, et al. A whole-cell computational model predicts phenotype from genotype. Cell 150 (2012), 389–401.
160. [160] Thiele, I., Fleming, R.M., Que, R., Bordbar, A., Diep, D., Palsson, B.O., Multiscale modeling of metabolism and macromolecular synthesis in E. coli and its application to the evolution of codon usage. PLoS ONE, 7, 2012, e45635.
161. [161] Macklin, D.N., Ruggero, N.A., Covert, M.W., The future of whole-cell modeling. Curr. Opin. Biotechnol. 28 (2014), 111–115.
162. [162] Raman, K., Chandra, N., Flux balance analysis of biological systems: applications and challenges. Brief. Bioinform. 10 (2009), 435–449.
163. [163] Klamt, S., Stelling, J., Stoichiometric and constraint-based modeling. Szallasi, Z., Stelling, J., Periwal, V., (eds.) System Modeling in Cellular Biology: From Concepts to Nuts and Bolts, 2006, MIT Press, Cambridge, Massachusetts.
164. [164] Palsson, B., The challenges of in silico biology. Nat. Biotechnol. 18 (2000), 1147–1150.
165. [165] Mahadevan, R., Schilling, C.H., The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab. Eng. 5 (2003), 264–276.
166. [166] Hilgetag, C., Schuster, S., On elementary flux modes in biochemical reaction systems at steady state. J. Biol. Syst. 2 (1994), 165–182.
167. [167] Schuster, S., Fell, D.A., Dandekar, T., A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks. Nat. Biotechnol. 18 (2000), 326–332.
168. [168] Schilling, C.H., Letscher, D., Palsson, B.Ø., Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective. J. Theor. Biol. 203 (2000), 229–248.
169. [169] Li, S., Huang, D., Li, Y., Wen, J., Jia, X., Rational improvement of the engineered isobutanol-producing Bacillus subtilis by elementary mode analysis. Microb. Cell Fact., 11, 2012, 101.
170. [170] Trinh, C.T., Elucidating and reprogramming Escherichia coli metabolisms for obligate anaerobic n-butanol and isobutanol production. Appl. Microbiol. Biotechnol. 95 (2012), 1083–1094.
171. [171] de Figueiredo, L.F., Schuster, S., Kaleta, C., Fell, D.A., Can sugars be produced from fatty acids? A test case for pathway analysis tools. Bioinformatics 25 (2009), 152–158.
172. [172] Rezola, A., Pey, J., Rubio, Á., Planes, F.J., In-silico prediction of key metabolic differences between two non-small cell lung cancer subtypes. PLoS ONE, 9, 2014, e103998.
173. [173] Rezola, A., Pey, J., de Figueiredo, L.F., Podhorski, A., Schuster, S., Rubio, A., et al. Selection of human tissue-specific elementary flux modes using gene expression data. Bioinformatics 29 (2013), 2009–2016.
174. [174] Varma, A., Palsson, B.Ø., Metabolic flux balancing: basic concepts, scientific and practical use. Nat. Biotechnol. 12 (1994), 994–998.
175. [175] Gambhir, A., Korke, R., Lee, J., Fu, P.C., Europa, A., Hu, W.S., Analysis of cellular metabolism of hybridoma cells at distinct physiological states. J. Biosci. Bioeng. 95 (2003), 317–327.
176. [176] Si, Y., Shi, H., Lee, K., Impact of perturbed pyruvate metabolism on adipocyte triglyceride accumulation. Metab. Eng. 11 (2009), 382–390.
177. [177] Schellenberger, J., Palsson, B.Ø., Use of randomized sampling for analysis of metabolic networks. J. Biol. Chem. 284 (2009), 5457–5461.
178. [178] Kaufman, D.E., Smith, R.L., Direction choice for accelerated convergence in hit-and-run sampling. Oper. Res. 46 (1998), 84–95.
179. [179] Megchelenbrink, W., Huynen, M., Marchiori, E., optGpSampler: an improved tool for uniformly sampling the solution-space of genome-scale metabolic networks. PLoS ONE, 9, 2014, e86587.
180. [180] Binns, M., de Atauri, P., Vlysidis, A., Cascante, M., Theodoropoulos, C., Sampling with poling-based flux balance analysis: optimal versus sub-optimal flux space analysis of Actinobacillus succinogenes. BMC Bioinform., 16, 2015, 49.
181. [181] Saa, P.A., Nielsen, L.K., II-ACHRB: a scalable algorithm for sampling the feasible solution space of metabolic networks. Bioinformatics 32 (2016), 2330–2337.